← FDA DRUG APPROVALS

FDA ANDA · ANDA077937

MELOXICAM

Sponsor: SUN PHARM INDS INC

APPLICATION
ANDA077937
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-19
LATEST ACTION
2008-12-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MELOXICAMDiscontinued
MELOXICAM 15MG · TABLET · ORAL
MELOXICAMDiscontinued
MELOXICAM 7.5MG · TABLET · ORAL

Approval history

2008-12-31Labeling · Supplement 9AP
2008-02-29Labeling · Supplement 4AP
2007-08-09Labeling · Supplement 3AP
2007-06-19Labeling · Supplement 1AP
2006-07-19OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →